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Abstract Influenza A viruses, members of the Orthomyx-
oviridae family, are responsible for annual seasonal
influenza epidemics and occasional global pandemics. The
binding of viral coat glycoprotein hemagglutinin (HA) to
sialylated glycan receptors on host epithelial cells is the
critical initial step in the infection and transmission of these
viruses. Scientists believe that a switch in the binding
specificity of HA from Neu5Acα2-3Gal linked (α2-3) to
Neu5Acα2-6Gal linked (α2-6) glycans is essential for the
crossover of the viruses from avian to human hosts.
However, studies have shown that the classification of
glycan binding preference of HA based on sialic acid
linkage alone is insufficient to establish a correlation
between receptor specificity of HA and the efficient
transmission of influenza A viruses. A recent study reported
extensive diversity in the structure and composition of α2-6
glycans (which goes beyond the sialic acid linkage) in
human upper respiratory epithelia and identified different
glycan structural topologies. Biochemical examination of
the multivalent HA binding to these diverse sialylated
glycan structures also demonstrated that high affinity
binding of HA to α2-6 glycans with a characteristic
umbrella-like structural topology is critical for efficient
human adaptation and human-human transmission of
influenza A viruses. This review summarizes studies which
suggest a new paradigm for understanding the role of the
structure of sialylated glycan receptors in influenza virus
pathogenesis.
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Introduction
Complex polysaccharides or glycans comprise a major part
of the cell surface and extra-cellular matrix of epithelial
cells [1]. Cell surface glycans, which are covalently
attached to proteins to form glycoconjugates, are highly
heterogeneous and can be linear or branched in structure.
Defining the structure-function relationships of these
glycans enabled the understanding of their diverse biolog-
ical roles [2, 3]. Glycans play a role in several physiological
and pathological processes, such as cell growth and
differentiation; cell-cell and cell-matrix signaling; cell
adhesion and tumor invasion; and metastasis; through their
interactions with growth factors, enzymes, and other
ligands [1, 2]. Studies have also indicated an important
role for these complex polysaccharides in microbial
pathogenesis and invasion. Several microbial pathogens
utilize glycans at the host cell surface and extracellular
environment as attachment sites or receptors that enhance
their ability to infect and invade host epithelia [4]. The
binding of pathogens to glycan receptors on host cells is
permitted by microbial surface proteins possessing specific
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carbohydrate recognition domains. Influenza A virus is a
pathogen that attaches to terminal sialic acid glycan
receptors on the host epithelial cell surface [5]. For several
decades scientists have known that the binding of the
influenza viral coat protein hemagglutinin (HA) to sialy-
lated glycans on the host cell surface is a key first step for
viral entry and infection [6]. Over the years however,
perception of the role that sialylated glycan receptors play
in this infection process has altered considerably. Advance-
ment of analytical techniques to characterize physiological
glycans, improved availability of co-crystal structures of
influenza hemagglutinin with sialylated glycan receptors [7]
and development of glycan arrays to study protein-glycan
interaction [8] have all significantly enhanced our under-
standing of the role of sialylated glycans in influenza A
virus pathogenesis.
Influenza viruses
Influenza A viruses are a major cause of flu epidemics
annually. In a typical year approximately 15% of the U.S.
population is infected, resulting in about 36,000 deaths and
more than 200,000 hospitalizations (www.cdc.gov/flu).
These viruses occasionally mutate to become highly
pathogenic—which could lead to a widespread pandemic
and serious global health concerns. Based on the estimated
mortality rate of the 1918 Spanish flu pandemic, epidemi-
ological studies predict that a modern pandemic would
affect as many as 75 million people worldwide.
Influenza A viruses are negative-sense, single-stranded
RNA viruses of the Orthomyxoviridae family [9]. These
viruses exist in a variety of shapes: ranging from spherical
particles to elongated filamentous forms, and sizes ranging
from 80–120 nm. Their genome consists of eight RNA
segments encodes for eleven viral proteins [9–12]. Three of
these proteins: hemagglutinin (HA), neuraminidase (NA),
and matrix protein (M1) are present on the surface of
influenza viruses. Other encoded proteins include RNA
polymerase subunits (PB1, PB2, PA), nucleoprotein (NP),
nonstructural proteins (NS1 and NS2), a proton-selective
ion channel protein (M2) and a newly discovered pro-
apoptotic PB1-F2 protein [13]. Influenza viruses lack a
proofreading mechanism in their RNA polymerase, which
causes the synthesis of new transcripts to be error prone.
Accumulations of these mutations permit the development
of new serotypes in a process known as antigenic drift. This
antigenic drift helps the virus evade its’ host immune
system by significantly refashioning the antigen present on
the surface. Transmembrane proteins HA and NA are the
antigenic determinants of these viruses and form the basis
for their classification into different serotypes. 16 HA and 9
NA serotypes have been identified thus far. The segmented
nature of viral RNA allows reassortment of genes between
viruses of different serotypes and results in new subtypes.
This process is called antigenic shift. Both antigenic drift
and antigenic shift are part of the evolution of an influenza
virus [14]. Antigenic drift is a continuous process and leads
to gradual changes in surface antigens while antigenic shift
is an occasional occurrence and leads to significant changes
in the antigen present on the virus surface.
Influenza viruses infect numerous animal species. Wild
aquatic birds serve as a natural reservoir for these viruses.
They also intermittently spread to other species such as
domestic birds, swine, and humans [15–18]. These viruses
are responsible for the seasonal flu epidemics and more
sporadic pandemics in humans. Two specific subtypes
(H1N1 and H3N2) of these viruses currently circulate in
humans and are the cause for seasonal flu epidemics.
Influenza A viruses occasionally evolve into highly
pathogenic and virulent strains either by acquiring
mutations or entire gene segments through reassortment
in a host infected by more than one viral strain. Highly
pathogenic strains yield a high mortality rate in humans
and efficiently transmit from human-to-human, which
results in widespread pandemic and serious global health
concerns [10, 11, 19, 20]. Among different strains of avian
influenza viruses such as H2N2, H5N1, H7N7 and H9N1,
which are currently known to infect humans, the H5N1 or
“bird flu” virus is by far the deadliest (with a mortality
rate greater than 60%, notably higher than pandemic
strains) [21–25]. Fortunately, these viruses have not yet
acquired the ability to efficiently transmit between humans
[26, 27]. Outbreaks have therefore been localized to
specific parts of the world. The H5N1 strains and others
have the potential to become serious global threats if they
mutate to adapt to human hosts and achieve efficient
human-human transmission.
The virus infection cycle of influenza A begins with the
attachment of the virus to glycan receptors on the host
cells. The virus is then internalized by endocytosis,
followed by membrane fusion and virus uncoating.
Subsequently, the viral RNA is transported to the nucleus
where it undergoes replication and transcription. Newly
synthesized proteins HA and NA are secreted through the
Golgi to the cell surface, while other proteins are trans-
ported to the nucleus to associate with the synthesized
transcripts of viral RNA and form virions. These virions
then bulge out of the cell membrane with HA and NA at
the surface. The action of neuraminidase facilitates the
release of these progeny viruses from their host cells that
go on to infect other cells.
Influenza viruses are well known for their ability to
agglutinate red blood cells (RBCs) in vitro. HA, which is
responsible for the agglutination, is a transmembrane
glycoprotein that exists as a homotrimer with the molecular
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weight of 220 kDa [28]. HA is a type 1 integral membrane
protein with a N-terminal hydrophobic signal sequence that
is cleaved off once the protein is anchored to the
membrane, a transmembrane anchoring domain near its C-
terminal, and a short hydrophilic cytoplasmic tail [7]. HA
plays an important role in different stages of viral
pathogenesis. As noted earlier, HA functions on the viral
surface as a glycan binding protein and enables viral
attachment to host epithelia by binding to sialylated glycan
receptors on the host cell surface. In subsequent steps of
viral pathogenesis, HA also undergoes a pH dependant
conformational change and aids in the fusion of viral and
host endosomal membranes post-endocytosis [6, 7].
Human glycan receptors for influenza virus infection
The ability of the virus to agglutinate chicken red blood
cells was first observed by Hirst et al. in 1941 [29], but it
was only in the 1950s that the identity of the receptor on
these erythrocytes was discovered. Pretreatment of eryth-
rocytes with culture filtrates of Vibrio cholerae destroyed
the ability of these erythrocytes to agglutinate in the
presence of influenza viruses [30]. The split product of
the enzyme treatment was subsequently shown to be sialic
acid [31–33]. Sialic acids are a diverse family of 9-carbon
monosaccharides, of which the most abundant member is
N-acetylneuraminic acid. They are negatively charged and
present either at the terminal position of the glycan or
linked to another sialic acid [34]. Sialic acid is added on to
N- or O-glycans by the sialyltransferase family of enzymes.
The sialyltransferase responsible for the addition of sialic
acid depends on the monosaccharide it is added to and the
linkage it is attached with. Sialic acid is linked to the
penultimate sugar—usually a galactose (Gal)—in either α2-3
linkage or α2-6 linkage. When sialic acid is added to another
sialic acid, it attaches with an α2-8 linkage.
Due to its terminal position, it is this monosaccharide
that is most likely to interact with extracellular molecules
including pathogens [35]. The human upper respiratory
tract is the primary site of influenza A virus infection and
the glycans on the epithelial cell surface that are human
receptors for these viruses are capped with sialic acid. Early
studies with lectin staining revealed that human tracheal
and bronchial epithelia predominantly express α2-6 sialy-
lated glycans [36]. Shinya et al. recently demonstrated the
extensive presence of α2-6 sialylated glycans in nasal
mucosa, on epithelial cells of paranasal sinuses and the
pharynx, and presence in the trachea and bronchi [37].
Human deep lung alveolar cells are, on the other hand,
lined with α2-3 sialylated glycans. It is important to note
that α2-3 sialylated glycans are extensively expressed at the
site of infection in birds [38].
Glycan receptor binding specificity of influenza virus
HA
Molecular HA-glycan interactions: crystal structure analysis
The HA crystal structure first resolved was the HA from the
H3N2 strain: A/Hong Kong/1968 by Wilson et al. [28]. This
trimeric HA unit is cylindrical with a length of 135 A and
radius varying between 15 to 40Å. It has a globular head
region that comprises the glycan binding site. Structures of
several HA proteins from H1, H3, H5, H7 and H9 subtypes
have also been solved, along with the co-crystal structures of
HA with α2-3 and/or α2-6 sialylated oligosaccharides [39–
45]. Analysis of these HA-glycan co-crystal structures
indicated that amino acids are involved in making contact
with the sialylated glycan. In each case, the position of
Neu5Ac sugar was found to be fixed relative to the HA
glycan binding site, with a highly conserved set of amino
acids: Tyr98, Ser/Thr136, Trp153, Thr155, His183, Leu/
Ile194 (amino acid numbering is based on H3 HA) across
different HA subtypes anchor the Neu5Ac [6]. The linkage of
Neu5Ac to the galactose (Gal) residue determines the cis- or
trans- conformation adopted by the glycan in the HA-glycan
co-crystal structures. In the HA-α2-3 co-crystal structures,
Neu5Acα2-3Gal (α2-3 motif) adopts a trans conformation. In
this conformation, in addition to the conserved anchor points
for sialic acid binding two critical residues of HA—Glu190
and Gln226—are involved in binding to the α2-3 motif.
Located at the base of the binding site, Gln226 interacts with
the glycosidic oxygen atom of the Neu5Acα2-3Gal linkage;
and, on the opposite side of Gln266, Glu190, interacts with
Neu5Ac and Gal monosaccharides [40, 41, 46]. In the HA-
α2-6 co-crystal structures, Neu5Acα2-6Gal (α2-6 motif)
contrarily adopts a cis conformation. In this conformation,
the critical amino acids of HA involved in stabilizing the
glycan interaction are subtype specific, but conserved
within a subtype. In H1 HAs, Lys222 and Asp225 are
positioned to interact with the oxygen atoms of the Gal in
the α2-6 motif and Asp190 and Ser/Asn193 interact with
additional monosaccharides GlcNAcβ1-3Gal linked to
α2-6 motif. Meanwhile, in H3 HAs, Leu226 and Ser228
are positioned to interact with the α2-6 motif.
Experimental methods to characterize HA-glycan interactions
Numerous methods have been developed to biochemically
characterize HA-glycan interactions. The earliest method
developed to probe the glycan specificity of HA was a
study of its ability to agglutinate red blood cells (RBCs).
RBCs from species such as chicken, turkey, equine, guinea
pigs, and humans have been used for these agglutination
assays [47–51]. The predominance of α2-3 on equine
RBCs and α2-6 on turkey and guinea pigs RBCs made
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them appropriate tools to probe HA specificity. RBCs from
almost all species possess both α2-3 and α2-6, so this
agglutination method was further modified to include a step
of complete desialylation of the RBCs, followed by
sialylation by specific α2-3- and α2-6- sialyltransferase,
to make the agglutination assay more reliable when probing
sialic acid linkage specificity. Subsequent development of
solid-phase fetuin capture assays offered a wealth of
information on the glycan binding properties of influenza
A viruses. In these assays, the viruses are immobilized on
fetuin-coated surfaces and their binding to various sialy-
lated glycans (including polyvalent compounds) is then
evaluated [16, 52–55]. The advent of the chemoenzymatic
synthesis of glycans and development of the glycan array
platform permitted study of the HA specificity to
chemically defined glycans [56–58]. Glycan arrays devel-
oped by the Consortium of Functional Glycomics (www.
functionalglycomics.org) comprise several α2-3 and α2-6
oligosaccharides, which cover motifs corresponding to
both O-linked and N-linked glycans [8, 59, 60]. Intact
viruses, recombinantly expressed HAs, and their mutant
forms (glycan-binding variants) from H1, H3, and H5
subtypes have already been analyzed using these glycan
arrays [8, 44, 61]. These studies have classified binding
preference based on the number of distinct α2-3 and α2-6
glycans that possess detectable binding signals for a given
HA. These studies also provide an understanding of the
effects of substitutions such as sulfation and fucosylation
and sugar modifications on the HA-glycan interactions.
HA-glycan interactions: receptor binding specificity
Inspection of the different influenza viruses using the
above-mentioned techniques reveals that HAs from differ-
ent species differ in their receptor specificity. This was first
demonstrated by Rogers and Paulson in 1983 using α2-3 or
α2-6 resialylated RBCs [48]. Most avian influenza viruses
predominantly bind to sialic acid in α2-3 linkage, whereas
the HAs from human adapted viruses predominantly
recognize sialic acid which is α2-6 linked to the underlying
sugar. Most studies focused on characterizing virus speci-
ficity based on sialic acid linkage only, but occasional
studies instead probed the influence of the internal sugars
on the viruses’ receptor specificity. Studies by Gambaryan
et al. showed the differences in the binding ability of
human adapted HAs to Neu5Acα2-6Galβ1-4GlcNAc and
Neu5Acα2-6Galβ1-4Glc [62]. Avian viruses isolated from
different species similarly show a common preference to
α2-3 sialylated glycans but differ in their recognition for
glycan modification beyond the Gal residue [53]. In spite
of these results, the sialic acid linkage was believed to be
the key determinant of receptor specificity and crossover
of the viruses from birds to humans was associated with
the ability of HA to switch its receptor specificity from
α2-3 sialylated glycans to α2-6 sialylated glycans.
HA-glycan binding: role of receptor specificity in viral
transmission
The ability to completely reconstruct the pandemic 1918
H1N1 viruses through reverse genetics predicated break-
throughs in the exploration of the roles of the different viral
genes—especially HA—and their virulence and transmissi-
bility [11, 63]. The relationship between the HA glycan
binding specificity and transmission efficiency was dem-
onstrated recently in a ferret model using the 1918 H1N1
viruses. Ferrets offer reliable animal models to study human
transmission of influenza viruses due to the predominance
of human-like α2-6 glycans in their upper respiratory tract
epithelium [26]. In the Tumpey et al. study a prototypic
1918 pandemic virus SC18 and two other variants were
used. One variant was created by mutating the Asp225 to
Gly225 on the HA to reflect natural variant A/New York/1/
18 (NY18) isolated from an archived lung sample. The
second variant (AV18) was created by introducing an
additional mutation (Asp190 to Glu190) on NY18 HA to
match the conserved HA sequence of avian H1N1 viruses.
SC18, NY18 and AV18 viruses differ only in their HA
sequence while all other 7 genes of the virus are identical.
The mutations in HA resulted in differences in their glycan
receptor binding preference. SC18 virus demonstrated a
preference for α2-6 sialylated glycans; NY18 showed
binding to both α2-3 and α2-6 sialylated glycans and
AV18 bound only to α2-3 sialylated glycans. In ferrets,
only the SC18 virus displayed efficient respiratory droplet
transmission. NY18 transmitted inefficiently and AV18 did
not transmit. These findings suggested that a switch in
viruses’ HA receptor specificity from α2-3 to α2-6
sialylated glycans could be imperative for efficient trans-
mission of these viruses. However in this same study, a
contemporary H1N1 strain, A/Texas/36/91 (Tx91) that had
a mixed α2-3/α2-6 binding was able to transmit efficiently
[50]. Observed differences in the transmissibility of NY18
and Tx91 despite their both having mixed α2-3/α2-6
sialylated glycans binding indicated that the “switch”
framework does not adequately explain the role of receptor
specificity of HA in human adaptation and transmission of
influenza A viruses. This observation requires the detailed
understanding of HA-glycan interaction, beyond their
binding to sialylated glycans with a specific linkage, and
the role of such interactions in virus transmission.
HA-glycan binding: sialic acid linkage and beyond
Agglutination and other traditional hemagglutination
assays enable the determination of viruses’ specificity
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according to the sialic acid linkage it binds to. However a
major drawback still remains in the failure to permit the
examination of specificity beyond this sialic acid linkage
per se. Other traditional methods, such as fetuin capture
assays [64, 65] offer the same limitations due to the
limited set of α2-3 and α2-6 sialylated oligosaccharides
used in these assays. This characterization of the glycan
binding specificity of influenza virus HA in terms of α2-3
and α2-6 sialic acid linkage alone does not adequately
capture the substantial diversity, chemical heterogeneity
and conformational flexibility of sialylated glycans or the
functional roles of the HA-glycan interactions.
The interaction of sialylated glycans with HA, as with other
glycan-protein interactions, is multivalent and involves an
ensemble of glycans making contact with the glycan-binding
site of the protein. Although the glycan binding affinity for a
single binding site on any glycan binding protein (such as a
lectin) is typically low (in the high μM to mM range), it is
compensated by the avidity effects of the multivalent interac-
tion. Multivalency further complicates the study of the
biochemical basis of HA-glycan interactions [66]. Assays
developed for studying HA-glycan interactions therefore need
to capture this multivalency.
The development of glycan array platforms has dramatically
expanded the diversity of glycans employed to investigate HA-
glycan interactions [8]. The presentation of glycans on the
array partly mimics the physiological presentation of glycans
on the cell surface. Glycan array binding of whole viruses
ensures the appropriate presentation of the viral HA. To
enhance the multivalent presentation of recombinantly
expressed HA proteins (partly mimicking the viral HA
presentation), methods have been developed to precomplex
the HA with labeled antibodies and detecting the binding
signal of the entire precomplexed units on the glycan array
[8]. Despite these developments, the major limitation in the
interpretation of the glycan array data arises from the assays
being performed with a single concentration of HA, or at a
single viral titer [8]. Analysis of the binding of HA to
sialylated glycans at a single HA concentration—especially in
saturating conditions—precludes observation of the finer
nuances of glycan specificity. Analysis at multiple concen-
trations—or viral titers—in the dynamic range of the assay
system would enable improved quantification of binding
affinity parameters.
These experimental challenges necessitate the develop-
ment of integrated approaches to permit study of complex
HA-glycan interactions [67]. A set of complementary
approaches would entail (1) an investigation of the diversity
of the sialic acid structures present in the human upper
airways, (2) a detailed analysis of the three dimensional
structure of the sialylated glycans predominantly expressed
in human upper airway epithelia, (3) a molecular under-
standing of HA-glycan interaction beyond the sialic acid
linkages, and (4) a thorough biochemical characterization
of HA-glycan binding specificities, which takes into
account the multivalent nature of these interactions [67].
When employing the above complementary approaches,
the first step is an analysis of the physiological glycan
receptors present in the upper airway and further charac-
terization of its structural attributes beyond simple sialic
acid linkage. The analysis of glycans directly from the
surface of human epithelia is confounded by challenges to
their accessibility. Glycan binding proteins such as plant
lectins are widely used to characterize glycans present on
human tissues. Although early studies with lectins such as
Sambucus nigra agglutinin (SNA-I) revealed the predom-
inance of α2-6 sialylated glycans on the epithelial surface
of human tracheal sections [68], recently a wider panel of
lectins has been used to elaborate the diversity of glycans
beyond the sialic acid linkages [67]. Lectin co-staining
experiments indentified a widespread distribution of N-
linked α2-6 sialylated glycans on the ciliated cells in
contrast with the localized distribution of O-linked α2-6
sialylated glycans on the goblet cells on the apical side of
the tracheal section [67]. A limitation in the availability of
glycans extracted form the tissues precludes their further
characterization. To gain further insight in the diversity of
glycan structures present, a representative upper airway cell
line was selected and glycans on their surface characterized
using MALDI-MS and MS-MS analytical techniques.
MALDI-MS profiling of N-linked sialylated glycans isolat-
ed from this representative human bronchial epithelial
(HBE) cell line showed the expected predominance of α2-
6 sialylated glycans. Moreover, substantial diversity was
found in the length and branching of the α2-6 sialylated
glycans present [67]. Further analysis of the major glycan
species present using MS/MS profiling revealed the
presence of long oligosaccharide branches with multiple
lactosamine repeats [67].
The diversity of α2-6 sialylated glycans present in the
upper airway prompted re-examination of the available
HA-glycan co-crystal structures and analyses of the
conformational features of these glycans, taking into
account additional parameters such as length and branch-
ing. The Neu5Ac (SA) sugar is fixed relative to the HA
glycan binding site in all the co-crystal structures. These
investigations also showed that the additional sugars
beyond the Neu5Ac adopt two distinct shapes or three-
dimensional topologies which provide optimal contacts
with the different HAs (Fig. 1). In one of the topologies,
the sugars underlying the SA (such as Gal, GlcNAc, etc.)
span a cone-like region on the HA glycan binding surface
and hence is known as cone-like topology. This topology
was typically adopted by α2-3 sialylated glycans, short
(di/tri-saccharide) α2-6 oligosaccharide motifs such as
6′-sialyl-lactose (or lactosamine) (Neu5Acα2-6Gal β1-
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4Glc(NAc)β1-), and 6′-sialyl-Tn- antigen (Neu5Acα2-
6GalNAcα1-). Another topology, identified as umbrella-
like was such that at least three sugars in addition to the
Neu5Ac spanned a wider region on the HA glycan binding
surface (as compared to the cone-like topology) that
resembled a space that could be defined by anywhere
between a fully-closed to a fully-opened umbrella. The
cone-like topology that could be adopted by sialylated
glycans having both α2-3 and α2-6 linkages but the
umbrella-like topology was unique to longer α2-6 oligo-
saccharide motifs such as 6′-sialyl-polylactosamine
(Neu5Acα2-6[Galβ1-4GlcNAcβ1-3]2-). The classifica-
tion of binding of HA to a particular glycan topology
adequately captures the effect of glycan structural diver-
sity on the specificity of HA-glycan interactions in
contrast to a classification based on HA binding to a
glycan of a specific α2-3 or α2-6 linkage in the trans or
cis conformations, respectively [67, 69].
Fig. 1 Structural topology of sialylated glycans. Shown at the top
is a schematic view of the umbrella-like and cone-like topologies that
respectively distinguish the glycan-receptors for the human-adapted
and the avian (and swine) influenza A viruses. This part of the figure
was adapted from Bewley, C.A. (2008) Nature Biotechnol. [69].
Shown in the middle is the propensity of the α2-3 and α2-6 sialylated
glycans to adopt the distinct cone-like and umbrella-like topologies.
The conformational energy maps of Neu5Acα2-3Gal, Neu5Acα2-
6Gal and Galβ1-4GlcNAc linkages in a trisaccharide (Neu5Acα2-3/
6Galβ1-4GlcNAc-) motif were obtained from GlycoMaps DB (http://
www.glycosciences.de/modeling/glycomapsdb/). The glycan topology
was characterized using a parameter θ (angle between C2 atom of
Neu5Ac and C1 atoms of subsequent Gal and GlcNAc sugars) for a
given set of (ϕ,ψ) angles between the linkages. The value of θ>110°
was used to characterize cone-like topology and θ<100° was used to
characterize umbrella-like topology. Superposition of the θ contour
with the conformational energy map indicated that α2-3 motif adopts
100% cone-like topology since it was energetically unfavorable to
adopt umbrella-like topology. On the other hand, the α2-6 motif
sampled both the cone-like and umbrella-like topologies and this
sampling was classified based on the ω angle (O-C6-C5-H5) of
Neu5Acα2-6Gal linkage. Shown in the bottom are the key HA residue
positions (numbered based on H3 HA) that interact with the specific
sugars in the cone-like and umbrella-like topologies
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HAs from a number of H1N1, H3N2 and H5N1 strains
and their mutants have been analyzed on the glycan array
for binding to previously defined glycan structures [44, 70].
Data mining analysis of existing glycan array data led to a
generation of classifiers or rules that correlate the binding
of different HAs to the various structural and conformational
features of the glycans on the array [67]. This analysis
revealed that the common feature between the HAs from
human adapted H1N1 and H3N2 viruses is their specific
binding to the long α2-6 glycans that adopt an umbrella-like
topology. Subsequent biochemical assays examined the
binding specificities of the different HAs and validated the
findings from these analyses. In this investigation HA
expressed in insect cells was presented in a multivalent
fashion to a previously determined representative set of
glycans with different linkages and topologies. As anticipat-
ed, the results correlated with previous analyses: the HAs
from human adapted H1 and H3 strains specifically bound to
the longer α2-6 oligosaccharide (with multiple lactosamine
repeats) which adopts the umbrella-like topology [67]. These
findings indicate that binding to glycans with a distinct
umbrella-like topology is critical for the human adaptation of
HA from influenza A viruses. This study also highlights the
finding that linkage alone cannot adequately explain the
human adaptation and transmission of influenza A viruses.
Glycan structure and topology are instead crucial consid-
erations in any examination of receptor specificities of
influenza viruses.
Revisiting the 1918 pandemic H1N1 virus
The above study redefined the criteria for the human
adaptation and transmission of influenza viruses by
accounting for the glycan topology and going beyond the
sialic acid linkages. Could a framework that classifies HA-
glycan interaction based on glycan topology shed light on
the differences in transmission of the different 1918 viruses
and also explain the conundrum of NY18 and Tx91
transmission? To answer this question, these new concepts
were applied to the 1918 H1N1 virus system. Based on the
transmission efficiencies of the different 1918 viruses, one
would expect that SC18 (which efficiently transmits in
ferret models) would bind to umbrella-like topology
glycans, while AV18 (with inefficient transmission) will
show minimal binding to umbrella-like glycans. The
analysis of binding of the mixed binding NY18 virus
(which inefficiently transmits in ferrets) to glycans with
different topologies would also provide useful insights for
understanding the role of receptor binding specificities in
viral transmission.
An in silico analysis of the HA-glycan co-crystal
structures revealed differences in the HA interaction with
glycans in cone-like and umbrella-like topology [71]. The
crystal structure of SC18 HA has been resolved and the
NY18 and AV18 structures were obtained in silico by
building mutations on this known structure of SC18. Co-
crystal model of SC18 with long α2-6 glycan in umbrella-
like topology indicate that the HA makes contact with the
glycan in two distinct regions. The Gal residue linked to
sialic acid forms the base region of the α2-6 motif and
additional monosaccharides GlcNAcβ1-3Gal form the
extension region of the α2-6 motif. In AV18 mutations
at positions 225 and 190 prevent it from making critical
contacts to the base and extension regions. This renders it
incapable of interaction with glycans in umbrella-like
topology. AV18 instead interacts with glycans in cone-like
topology. The absence of the critical Glu190 residue in
SC18 and NY18 HAs makes their interaction with glycans
in cone-like glycan topology less optimal in comparison
with AV18 HA.
Differences in the binding specifities of SC18, NY18
and AV18 HAs to glycans in cone-like and umbrella-like
topologies were captured in direct binding assays with
plated glycans. To capture the multivalent nature of HA-
glycan interactions, SC18, NY18 and AV18 HAs were
precomplexed with primary and secondary antibodies (HA:
primary: secondary = 4:2:1 ratio). This allowed exploration
into the effects of the relative spatial positioning of multiple
HA units on glycan binding affinity. By performing these
assays in a dose dependent fashion, the relative glycan
binding affinities of HAs with long and short α2-6 and α2-
3 were also evaluated. Quantitative parameters such as the
apparent binding constant K
0
d and cooperativity factor n
were calculated by fitting binding data to a linearized Hill
model. As anticipated from the analysis of co-crystal
structures, SC18 HA showed high binding affinity to the
long α2-6 sialylated glycan. Also as expected, AV18 HA
showed minimal binding to α2-6 sialylated glycans and
high binding affinity to α2-3 sialylated glycans. Interest-
ingly, NY18 HA showed binding to umbrella-like topology
glycans, but had a significantly lower binding affinity in
comparison with SC18 for long α2-6 sialylated glycans.
HAs from other representative human adapted viruses (such
as H3N2) also displayed high binding affinities for
umbrella-like topology glycans. These findings suggest that
binding to umbrella-like topology glycans with high
binding affinities is critical for efficient human to human
transmission of the virus [71].
In a similar analysis, Tx91 HAwas shown to have binding
affinities comparable to those of SC18 for the umbrella
topology glycan. The observed difference in the binding
affinities of Tx91 and NY18HA to longα2-6 or umbrella-like
glycans could explain the observed difference in transmission
of these viruses despite a shared mixed α2-3/α2-6 binding
[71].
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Physiological relevance of HA binding to glycans
Despite the advantages that glycan array assays offer in
terms of valuable information about the glycan specificity
of HA, our understanding of HA-glycan interaction is
incomplete without elucidating its physiological relevance.
Glycan arrays possess various glycan motifs but still do not
capture the diversity of glycans present on the cell surface. It is
important to bridge the glycan specificity of HA on the array
to its ability to bind to glycan receptors at the site of infection.
Pre-complexed HA from different strains have been used in a
manner similar to plant lectins, to stain tracheal tissue
sections. Tracheal tissue contains multiple cell types including
cartilage ring, pseudostratified ciliated epithelium, goblet cells
and submucosal gland cells. From these, the ciliated cells and
goblet cells are exposed on the surface and glycans on these
cells are potential receptors for influenza viruses.
Notably, the HAs from human-adapted viruses (such as
SC18 and two representative H3N2 viruses) examined in
the preceding analyses bind to the apical side of the tracheal
epithelium, which lectin and MS analysis show a predom-
inant expression of glycans, which adopt the umbrella-like
topology. Comparison of binding patterns of SC18 and
NY18 HA to the apical side of the trachea reveals a more
restricted binding of SC18 when compared to the well-
distributed binding of NY18 [71]. This suggests that SC18
binds to more selective cell types than NY18. Observation
of differences in the binding patterns of HAs from different
viruses requires further investigation of the structural and
conformational diversity of the N-linked and O-linked
sialylated glycans in these different cell types in the trachea.
The diversity and distribution of sialylated glycans in each
cell type could determine the cellular tropism of the
different influenza A viruses. Additional study is needed
to examine the correlation between these viral tropisms and
differences in the efficiency of the transmission of influenza
A viruses. Little is still known about the structure and
composition of sialylated glycans in other human upper
respiratory tissues such as nasopharangeal, bronchial and
alveolar. A combination of lectin staining of these tissues and
MS analysis of representative cell lines could provide
valuable information on the composition and topologies of
the glycan receptors expressed in the human respiratory tract.
Implications for H5N1 and future work
Avian H5N1 virus strains currently circulate worldwide and
cause epidemics in poultry. Since 1997 occasional reports of
these viruses infecting humans have emerged. These viruses
have a very high mortality rate but have not yet achieved
efficient human-human transmission. Glycan array analysis of
these strains reveals their propensity to bind toα2-3 sialylated
glycans [44, 70]. Although some of these strains and some
lab-created mutants have been shown to have binding to α2-
6 sialylated glycans, they still lack the ability to cause
human-to-human transmission. This is because the α2-6
binding of these viruses are either limited to short α2-6
sialylated glycans that take the cone-like topology similar to
α2-3 sialylated glycans or—even if the viruses bind to long
α2-6 sialylated glycans—their binding affinity is low [67].
Performance of the assay in a dose dependent fashion
to capture affinity and characterization of the ability of
the virus to bind to glycans in umbrella-like topology
would facilitate the determination of HAs’ actual adap-
tation for human-to-human transmission as well as permit
for effective surveillance of their evolution into potential
pandemic human viruses. Further defining the determi-
nant for human adaptation of HA allows for the rational
design and experimental validation of HA mutations that
would enable high affinity binding to the α2-6 glycan
receptors with the characteristic umbrella-like topology.
This knowledge would enhance our preparedness for any
pandemic threat and facilitatethe development of prophy-
lactic vaccines and possible glycomimetic therapeutics.
Concluding remarks
The attachment of HA on the influenza virus to the sialylated
glycan receptors on the cell surface is the first step in the
infection cycle. This HA-glycan interaction plays an important
role in virus infection and transmission. This interaction has
long been classified by the cis or trans conformation the
glycan takes. Defining the binding specificity of HA based
on the terminal linkage motif (Neu5Acα2-3Gal- or
Neu5Acα2-3Gal-) alone provides a simplistic view of its
complex multivalent interactions with a diverse set of
glycans and does not readily correlate with human adaptation
of HA and human-to-human transmission of these viruses.
Capturing glycan characteristics beyond the terminal linkage
has led to the classification of sialylated glycans taking cone-
like and umbrella-like topologies. The ability of HA to bind
glycans in an umbrella-like topology appears critical for
human adaptation and transmission. Most significantly, in
defining distinct structural topologies for sialylated glycans,
we put forth a concept to distinguish the α2-3 and α2-6
binding of avian HAs from that of the α2-6 binding of
human adapted H1 and H3 HAs and enable the correlation of
HA glycan specificity to human adaptation and transmission.
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